Caring for patients using virtual reality
With is neurological rehabilitation system, MindMaze is now worth over a billion dollars, making it the first Swiss unicorn.
MindMaze is a spin-off from the EPFL which has revolutionized neurological treatment with a technology that facilitates and accelerates the rehabilitation of CVA (stroke) victims via virtual reality.
"In the event of lesions on the brain, the first three or four weeks afterwards are absolutely critical," explains Pierre-Emmanuel Meyer, CFO of the company. "The MindMaze team, who all have a neuroscience background, have therefore looked to develop a system which can act rapidly on neurological rehabilitation."